iSpecimen Inc.
ISPC
$1.55
-$0.04-2.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 466.30K | 1.03M | 1.93M | 3.35M | 5.91M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 466.30K | 1.03M | 1.93M | 3.35M | 5.91M |
| Cost of Revenue | 971.10K | 1.33M | 1.90M | 2.63M | 3.98M |
| Gross Profit | -504.80K | -304.50K | 24.10K | 722.60K | 1.93M |
| SG&A Expenses | 7.30M | 7.71M | 6.84M | 10.27M | 10.15M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.89M | 10.91M | 10.91M | 15.48M | 16.91M |
| Operating Income | -9.42M | -9.88M | -8.98M | -12.13M | -11.01M |
| Income Before Tax | -11.42M | -11.10M | -10.49M | -11.53M | -10.19M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.42 | -11.10 | -10.49 | -11.53 | -10.19 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.42M | -11.10M | -10.49M | -11.53M | -10.19M |
| EBIT | -9.42M | -9.88M | -8.98M | -12.13M | -11.01M |
| EBITDA | -9.29M | -9.68M | -8.72M | -11.87M | -10.75M |
| EPS Basic | -52.63 | -68.43 | -90.32 | -278.17 | -342.94 |
| Normalized Basic EPS | -32.89 | -42.77 | -56.45 | -173.86 | -214.34 |
| EPS Diluted | -52.63 | -68.43 | -90.32 | -278.17 | -342.94 |
| Normalized Diluted EPS | -32.89 | -42.77 | -56.45 | -173.86 | -214.34 |
| Average Basic Shares Outstanding | 2.07M | 742.60K | 459.30K | 294.80K | 166.00K |
| Average Diluted Shares Outstanding | 2.07M | 742.60K | 459.30K | 294.80K | 166.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |